Masarykuv onkologicky ustav ( Site 0903)

Brno, Brno-mesto 656 53

2 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Renal Cell, Renal Cell Carcinoma

Studies at this site

• A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033) — Recruiting now
• A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034) — Recruiting now